SignatureFD’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
67,323
+13,838
+26% +$335K 0.02% 306
2026
Q1
$1.3M Buy
53,485
+44,004
+464% +$1.07M 0.02% 331
2025
Q4
$230K Sell
9,481
-2,254
-19% -$54.8K ﹤0.01% 891
2025
Q3
$286K Buy
11,735
+10,074
+607% +$244K ﹤0.01% 794
2025
Q2
$40.3K Hold
1,661
﹤0.01% 1703
2025
Q1
$40.2K Buy
+1,661
New +$39.9K ﹤0.01% 1704
2024
Q3
Sell
-1,000
Closed -$23.7K 3279
2024
Q2
$23.7K Buy
+1,000
New +$23.6K ﹤0.01% 1880

Other funds holding IBDS

SignatureFD's IBDS Position: Q2 2026 in Review

SignatureFD increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 26% in Q2 2026, buying an estimated $335K and bringing the position to 67,323 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #306.

SignatureFD first reported a position in IBDS in Q2 2024 and has held it in 7 quarters since. 140 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • SignatureFD held 67,323 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $1.63M as of Q2 2026.
  • SignatureFD bought 13,838 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $335K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.02% of SignatureFD's portfolio in Q2 2026, its #306 holding.
  • SignatureFD first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2024 and has held it in 7 quarters since.
  • 140 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.